{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:50:14Z","timestamp":1791280214223,"version":"4.1.0"},"reference-count":56,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius Foundation","doi-asserted-by":"publisher","award":["TWINSIGHT-12"],"award-info":[{"award-number":["TWINSIGHT-12"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"award":["TWINSIGHT-12"],"award-info":[{"award-number":["TWINSIGHT-12"]}],"id":[{"id":"https:\/\/ror.org\/03zcxha54","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Dysgeusia is a clinically consequential, but still under-standardized, toxicity of cancer treatment. In the immunotherapy era, taste disturbances are increasingly relevant for patients receiving immune checkpoint inhibitors, chimeric antigen receptor (CAR) T-cell therapies and T-cell-redirecting bispecific antibodies, with G protein-coupled receptor family C group 5 member D (GPRC5D)-directed treatment in multiple myeloma representing a particularly instructive high-burden model. We performed a structured critical narrative review with evidence mapping. PubMed\/MEDLINE was searched from database inception to June 2026, complemented by citation tracking in Google Scholar, ClinicalTrials.gov searches and guideline documents relevant to oncology nutrition, oral supportive care and cancer-related taste dysfunction. Search concepts covered cancer-related dysgeusia, immunotherapy-associated oral toxicity, GPRC5D\/talquetamab-associated dysgeusia, oncology nutrition, oral\u2013gut microbiome biology, natural taste modulators and miraculin-based interventions. Dysgeusia can reduce appetite, food enjoyment, dietary diversity and protein energy intake, thereby contributing to weight loss, malnutrition risk, distress, social withdrawal and, in severe cases, treatment modification or discontinuation. Available evidence is heterogeneous: general cancer-treatment-associated dysgeusia is supported by broader observational and interventional literature; immunotherapy-associated dysgeusia is less systematically characterized; and GPRC5D\/talquetamab-associated dysgeusia represents the most clinically visible and target-specific immunotherapy-associated phenotype. Emerging pilot data suggest that dried miracle berry or miraculin-containing products may improve selected taste perception and nutritional parameters in cancer-related dysgeusia, but direct evidence in immunotherapy-associated dysgeusia is not yet established. We, therefore, propose a claim-disciplined precision supportive-care framework integrating systematic taste phenotyping, early nutritional risk assessment, oral health evaluation, microbiome-aware but hypothesis-generating endpoints, individualized flavor and texture adaptation, cautious use of natural taste modulators in selected patients and iterative monitoring of patient-centered outcomes. Future trials should test whether dysgeusia-focused nutritional and taste-modulating supportive care interventions can improve intake, quality of life and treatment persistence without compromising immunotherapy safety or efficacy.<\/jats:p>","DOI":"10.3390\/nu18142393","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:20:39Z","timestamp":1784712039000},"page":"2393","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Natural Taste Modulators and Microbiome-Aware Nutritional Support for Immunotherapy-Associated Dysgeusia: A Translational Perspective for Precision Supportive Cancer Care"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8760-3931","authenticated-orcid":false,"given":"Anna","family":"Fleischer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II\/Psychosomatics, University Hospital W\u00fcrzburg, 97080 W\u00fcrzburg, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"ref_1","first-page":"1081","article-title":"A systematic review of dysgeusia induced by cancer therapies","volume":"18","author":"Hovan","year":"2010","journal-title":"Support. Care Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jpainsymman.2011.11.011","article-title":"Coming to your senses: Detecting taste and smell alterations in chemotherapy patients. A systematic review","volume":"44","author":"Gamper","year":"2012","journal-title":"J. Pain Symptom Manag."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Rosati, D., Mastino, P., Romeo, M., de Soccio, G., Pentangelo, D., Petrella, C., Barbato, C., and Minni, A. (2024). Taste and Smell Alterations (TSAs) in Cancer Patients. Diseases, 12.","DOI":"10.3390\/diseases12060130"},{"key":"ref_4","first-page":"303","article-title":"The role of food during oncology treatment: Perspectives of cancer patients, caregivers and healthcare professionals","volume":"32","author":"Adamczyk","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ctrv.2011.04.008","article-title":"The influence of chemotherapy on taste perception and food hedonics: A systematic review","volume":"38","author":"Boltong","year":"2012","journal-title":"Cancer Treat. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Milliron, B.J., Packel, L., Dychtwald, D., Klobodu, C., Pontiggia, L., Ogbogu, O., Barksdale, B., and Deutsch, J. (2022). When Eating Becomes Torturous: Understanding Nutrition-Related Cancer Treatment Side Effects among Individuals with Cancer and Their Caregivers. Nutrients, 14.","DOI":"10.3390\/nu14020356"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"102735","DOI":"10.1016\/j.ejon.2024.102735","article-title":"Prevalence and risk factors of chemotherapy-induced taste alterations among cancer patients: A systematic review and meta-analysis","volume":"74","author":"Zhang","year":"2025","journal-title":"Eur. J. Oncol. Nurs."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Garutti, M., Noto, C., Past\u00f2, B., Cucciniello, L., Alajmo, M., Casirati, A., Pedrazzoli, P., Caccialanza, R., and Puglisi, F. (2023). Nutritional Management of Oncological Symptoms: A Comprehensive Review. Nutrients, 15.","DOI":"10.3390\/nu15245068"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1056\/NEJMoa2204591","article-title":"Talquetamab, a T-Cell\u2013Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma","volume":"387","author":"Chari","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3324\/haematol.2023.283931","article-title":"Talquetamab in multiple myeloma","volume":"109","author":"Liu","year":"2024","journal-title":"Haematologica"},{"key":"ref_11","first-page":"20","article-title":"Characterization of dysgeusia and xerostomia in patients with multiple myeloma treated with the T-cell redirecting GPRC5D bispecific antibody talquetamab","volume":"32","author":"Laheij","year":"2023","journal-title":"Support. Care Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jha2.971","article-title":"Weight loss and dysgeusia in relapsed\/refractory multiple myeloma patients treated with talquetamab","volume":"5","author":"Naqvi","year":"2024","journal-title":"eJHaem"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e71401","DOI":"10.1002\/cam4.71401","article-title":"Talquetamab-Related Dysgeusia in Multiple Myeloma Compared to BCMA-Targeted Bispecifics and High-Dose Melphalan","volume":"14","author":"Fleischer","year":"2025","journal-title":"Cancer Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/CMAR.S441550","article-title":"Perspectives on Talquetamab and its Utility in the Treatment of Multiple Myeloma: Safety, Efficacy and Place in Therapy","volume":"17","author":"Miller","year":"2025","journal-title":"Cancer Manag. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1046\/j.0022-202X.2004.12628.x","article-title":"The RAIG family member, GPRC5D, is associated with hard-keratinized structures","volume":"122","author":"Inoue","year":"2004","journal-title":"J. Investig. Dermatol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"eaau7746","DOI":"10.1126\/scitranslmed.aau7746","article-title":"GPRC5D is a target for the immunotherapy of multiple myeloma with rationally designed CAR T cells","volume":"11","author":"Smith","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_17","first-page":"668","article-title":"Supportive care for talquetamab-related dysgeusia in multiple myeloma: Mixed-methods evidence, nutrition-focused flowchart, and digital companion concept","volume":"34","author":"Fleischer","year":"2026","journal-title":"Support. Care Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical Nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin. Nutr."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines\u2606","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"},{"key":"ref_21","first-page":"549","article-title":"MASCC\/ISOO Clinical Practice Statement: Management of oral complications of targeted therapy","volume":"32","author":"Villa","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_22","first-page":"548","article-title":"MASCC\/ISOO Clinical Practice Statement: Management of salivary gland hypofunction and xerostomia in cancer patients","volume":"32","author":"Hong","year":"2024","journal-title":"Support. Care Cancer"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/JLB.3MR0320-444R","article-title":"Natural products and their derivatives: Promising modulators of tumor immunotherapy","volume":"108","author":"Deng","year":"2020","journal-title":"J. Leukoc. Biol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Huo, J.-L., Fu, W.-J., Liu, Z.-H., Lu, N., Jia, X.-Q., and Liu, Z.-S. (2022). Research advance of natural products in tumor immunotherapy. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.972345"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Yao, P., Liang, S., Liu, Z., and Xu, C. (2024). A review of natural products targeting tumor immune microenvironments for the treatment of lung cancer. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1343316"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhang, W., Li, S., Li, C., Li, T., and Huang, Y. (2022). Remodeling tumor microenvironment with natural products to overcome drug resistance. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.1051998"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Song, P., Song, F., Shao, T., Wang, P., Li, R., Chen, Z.-S., Zhang, Z., and Xue, G. (2024). Natural products: Promising therapeutics for targeting regulatory immune cells in the tumor microenvironment. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1481850"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Chen, Y., Wang, Z., Zhang, C., Su, Y., Zhou, T., and Hu, K. (2024). Revealing the mechanism of natural product-induced immunogenic cell death: Opening a new chapter in tumor immunotherapy. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1470071"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12032-025-02998-6","article-title":"Oral microbiome alterations after cancer treatment: A scoping review and analysis","volume":"42","author":"Boksa","year":"2025","journal-title":"Med. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Szczyrek, M., Bitkowska, P., Chunowski, P., Czuchryta, P., Krawczyk, P., and Milanowski, J. (2021). Diet, Microbiome, and Cancer Immunotherapy\u2014A Comprehensive Review. Nutrients, 13.","DOI":"10.3390\/nu13072217"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1186\/s12967-025-06586-0","article-title":"Gut microbiome changes and cancer immunotherapy outcomes associated with dietary interventions: A systematic review of preclinical and clinical evidence","volume":"23","author":"Somodi","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"15347354241269870","DOI":"10.1177\/15347354241269870","article-title":"Targeting the Gut Microbiome to Improve Immunotherapy Outcomes: A Review","volume":"23","author":"David","year":"2024","journal-title":"Integr. Cancer Ther."},{"key":"ref_33","first-page":"2125","article-title":"Chemotherapy-induced taste and smell changes influence food perception in cancer patients","volume":"29","author":"Drareni","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ctrv.2016.03.006","article-title":"The effects of swallowing disorders, dysgeusia, oral mucositis and xerostomia on nutritional status, oral intake and weight loss in head and neck cancer patients: A systematic review","volume":"45","author":"Bressan","year":"2016","journal-title":"Cancer Treat. Rev."},{"key":"ref_35","first-page":"2","article-title":"Quantitative assessment of gustatory function in a clinical context using impregnated \u201ctaste strips\u201d","volume":"41","author":"Mueller","year":"2003","journal-title":"Rhinology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00415-009-0088-y","article-title":"\u201cTaste Strips\u201d\u2014A rapid, lateralized, gustatory bedside identification test based on impregnated filter papers","volume":"256","author":"Landis","year":"2009","journal-title":"J. Neurol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"15347354231159309","DOI":"10.1177\/15347354231159309","article-title":"Characterization of Oral Microbiota Following Chemotherapy in Patients with Hematopoietic Malignancies","volume":"22","author":"Omori","year":"2023","journal-title":"Integr. Cancer Ther."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti\u2013PD-1 immunotherapy in melanoma patients","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1\u2013based immunotherapy against epithelial tumors","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti\u2013PD-1 efficacy in metastatic melanoma patients","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1126\/science.abb5920","article-title":"Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients","volume":"371","author":"Baruch","year":"2021","journal-title":"Science"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1126\/science.abf3363","article-title":"Fecal microbiota transplant overcomes resistance to anti\u2013PD-1 therapy in melanoma patients","volume":"371","author":"Davar","year":"2021","journal-title":"Science"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1126\/science.aaz7015","article-title":"Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response","volume":"374","author":"Spencer","year":"2021","journal-title":"Science"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2014-12-615187","article-title":"Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An International Myeloma Working Group report","volume":"125","author":"Palumbo","year":"2015","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41409-020-01008-9","article-title":"Prevalence and significance of sarcopenia in multiple myeloma patients undergoing autologous hematopoietic cell transplantation","volume":"56","author":"Williams","year":"2021","journal-title":"Bone Marrow Transpl."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1158\/2643-3230.BCD-24-0124","article-title":"T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma: Optimal Dosing Schedule and Duration of Treatment","volume":"5","author":"Rasche","year":"2024","journal-title":"Blood Cancer Discov."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/jnci\/85.5.365","article-title":"The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology","volume":"85","author":"Aaronson","year":"1993","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/sj.ejcn.1601412","article-title":"Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer","volume":"56","author":"Bauer","year":"2002","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0261-5614(02)00214-5","article-title":"Nutritional risk screening (NRS 2002): A new method based on an analysis of controlled clinical trials","volume":"22","author":"Kondrup","year":"2003","journal-title":"Clin. Nutr."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1904::AID-CNCR13>3.0.CO;2-X","article-title":"Rapid screening for psychologic distress in men with prostate carcinoma: A pilot study","volume":"82","author":"Roth","year":"1998","journal-title":"Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Plaza, B., Gil, \u00c1., Men\u00e9ndez-Rey, A., Bensadon-Naeder, L., Hummel, T., Feli\u00fa-Batlle, J., and Palma-Milla, S. (2023). Effect of Regular Consumption of a Miraculin-Based Food Supplement on Taste Perception and Nutritional Status in Malnourished Cancer Patients: A Triple-Blind, Randomized, Placebo-Controlled Clinical Trial\u2014CLINMIR Pilot Protocol. Nutrients, 15.","DOI":"10.20944\/preprints202310.0649.v1"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"E173","DOI":"10.1188\/12.CJON.E173-E177","article-title":"Pilot study of \u201cmiracle fruit\u201d to improve food palatability for patients receiving chemotherapy","volume":"16","author":"Wilken","year":"2012","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Plaza, B., \u00c1lvarez-Mercado, A.I., Arcos-Castellanos, L., Plaza-Diaz, J., Ruiz-Ojeda, F.J., Brandimonte-Hern\u00e1ndez, M., Feli\u00fa-Batlle, J., Hummel, T., Gil, \u00c1., and Palma-Milla, S. (2024). Efficacy and Safety of Habitual Consumption of a Food Supplement Containing Miraculin in Malnourished Cancer Patients: The CLINMIR Pilot Study. Nutrients, 16.","DOI":"10.1101\/2024.05.15.24307453"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Plaza-Diaz, J., Ruiz-Ojeda, F.J., L\u00f3pez-Plaza, B., Brandimonte-Hern\u00e1ndez, M., \u00c1lvarez-Mercado, A.I., Arcos-Castellanos, L., Feli\u00fa-Batlle, J., Hummel, T., Palma-Milla, S., and Gil, A. (2024). Effect of a Novel Food Rich in Miraculin on the Oral Microbiome of Malnourished Oncologic Patients with Dysgeusia. Cancers, 16.","DOI":"10.1101\/2024.07.12.24310343"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Plaza-Diaz, J., Brandimonte-Hern\u00e1ndez, M., L\u00f3pez-Plaza, B., Ruiz-Ojeda, F.J., \u00c1lvarez-Mercado, A.I., Arcos-Castellanos, L., Feli\u00fa-Batlle, J., Hummel, T., Palma-Milla, S., and Gil, A. (2025). Effect of a Novel Food Rich in Miraculin on the Intestinal Microbiome of Malnourished Patients with Cancer and Dysgeusia. Nutrients, 17.","DOI":"10.3390\/nu17020246"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez-Mercado, A.I., L\u00f3pez-Plaza, B., Plaza-Diaz, J., Arcos-Castellanos, L., Ruiz-Ojeda, F.J., Brandimonte-Hern\u00e1ndez, M., Feli\u00fa-Batlle, J., Hummel, T., Palma-Milla, S., and Gil, \u00c1. (2025). Miraculin Can Contribute to a Reduction in Inflammatory Biomarkers and Cachexia in Malnourished Patients with Cancer and Taste Disorders. Pharmaceuticals, 18.","DOI":"10.3390\/ph18050622"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/14\/2393\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T09:30:22Z","timestamp":1784712622000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/18\/14\/2393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":56,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["nu18142393"],"URL":"https:\/\/doi.org\/10.3390\/nu18142393","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]}}}